# GSK sales rise as reported and core operating profit diverge

> GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates.

- Canonical URL: https://newsverum.com/en/news/gsk-third-quarter-sales-total-core-profit-currency-2026
- Publisher: Newsverum
- Section: Business
- Country: United Kingdom
- Published: 2026-10-28T19:46:24+00:00
- Updated: 2026-10-28T19:46:24+00:00
- Event / data period: 2026-09
- Other editions: [Türkçe](https://newsverum.com/tr/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md), [العربية](https://newsverum.com/ar/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md), [Français](https://newsverum.com/fr/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md), [Español](https://newsverum.com/es/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md), [Deutsch](https://newsverum.com/de/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md), [Português](https://newsverum.com/pt/news/gsk-third-quarter-sales-total-core-profit-currency-2026.md)

GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds.

Core operating profit rose 3% at actual exchange rates to 3.076 billion pounds, or 5% at constant exchange rates. The company linked the difference between total and core performance partly to restructuring charges of 328 million pounds and lower other net operating income. Core results are non-IFRS measures and do not replace reported results.

GSK reaffirmed full-year guidance for turnover growth of 3–5% and core operating profit growth of 7–9%, both at constant exchange rates. These expectations are forecasts. Currency-adjusted growth, reported growth and the company’s core measures describe different comparisons and should not be combined into one profit figure.

## Data

### Source publication

Publication of the official announcement on 28 October 2026.

Methodology: The date records publication of the cited official source. It does not establish completion of announced future actions.

| date | label | description | status |
|---|---|---|---|
| 2026-10-28 | GSK sales rise as reported and core operating profit diverge | GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds. | occurred |

Sources: <https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/> · Download data: [JSON](https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=en&format=csv)

## Sources

- [GSK](<https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/>) (Source checked: 2026-10-28; Published: 2026-10-28)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)
